-+ 0.00%
-+ 0.00%
-+ 0.00%

Camp4 Therapeutics Reports Q3 2025 Results and Advances SYNGAP1 Program Toward Clinical Trials

Reuters·11/06/2025 21:24:56

Please log in to view news